Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Immix Biopharma Prices $125 Million Stock Offering

Immix Biopharma Prices $125 Million Stock Offering

MT newswireMT newswire2026/09/29 12:30
08:30 AM EDT, 09/29/2026 (MT Newswires) -- Immix Biopharma (IMMX) said Tuesday it priced an underwritten offering of about 11.4 million common shares at $11 apiece. The offering, which will likely yield gross proceeds of $125 million, is expected to close around Wednesday, the company said. Immix Biopharma also said it plans to use the net proceeds to finance NXC-201 development, working capital and general corporate purposes.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share

Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.

华尔街见闻•2026/11/21 12:01
Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share